<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.moneycontrol.com/news/business/unichem-labs-gets-usfda-nod-to-market-anxiety-disorder-tablets-4644041.html"/>
    <meta property="og:site_name" content="Moneycontrol"/>
    <meta property="article:published_time" content="2019-11-15T00:00:00+00:00"/>
    <meta property="og:title" content="Unichem Labs gets USFDA nod to market anxiety disorder tablets"/>
    <meta property="og:description" content="The company has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) to market its Buspirone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, and 30 mg, Unichem Laboratories said in a BSE filing."/>
  </head>
  <body>
    <article>
      <h1>Unichem Labs gets USFDA nod to market anxiety disorder tablets</h1>
      <h2>The company has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) to market its Buspirone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, and 30 mg, Unichem Laboratories said in a BSE filing.</h2>
      <address><time datetime="2019-11-15T00:00:00+00:00">15 Nov 2019</time> by <a rel="author">PTI</a></address>
      <p>Drug firm <a href="http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/unichemlaboratories/UL02">Unichem Laboratories</a> on Friday said it has received approval from the US health regulator to market its generic Buspirone Hydrochloride tablets used for management of anxiety disorders.</p>
      <p>The company has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) to market its Buspirone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, and 30 mg, Unichem Laboratories said in a BSE filing.</p>
      <p>The company's tablets are a generic version of Bristol-Myers Squibb Company's Buspar tablets in the same strengths, it added.</p>
      <p>
        <a href="https://www.moneycontrol.com/news/business/javascript:;">Close</a>
      </p>
      <p>The product will be commercialised from the company's Ghaziabad plant, Unichem said.</p>
      <p>Buspirone Hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety, it added.</p>
      <p>Shares of Unichem Laboratories closed at Rs 149.85 per scrip on BSE, up 5.16 per cent from its previous close.<a href="https://www.moneycontrol.com/promos/pro.php">Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights &amp; analysis For more information, check out the Moneycontrol website or mobile app.</a></p>
    </article>
  </body>
</html>